Introduction
In the face of cold exposure, mammals typically activate a thermogenic program within white adipose tissue (WAT). This process, known as "beiging," involves the sympathetic nervous system (SNS) triggering the expression of Uncoupling Protein 1 (UCP1) in adipocytes, which allows them to burn energy to generate heat. However, a long-standing observation in metabolic research is that female subcutaneous WAT (scWAT)—specifically the mammary gland-associated fat—is remarkably resistant to this process compared to male fat depots.
A recent study identifies the culprit behind this resistance: the mammary ductal epithelium itself. Rather than being a passive bystander, the mammary gland acts as a "metabolic brake," secreting a suite of proteins termed "mammokines" that actively suppress adipocyte thermogenesis to preserve energy stores.
The Discovery of "Mammokines"
Using single-cell RNA sequencing (scRNA-seq) on the stromal vascular fraction of mammary gland WAT (mgWAT), researchers identified that cold exposure triggers a specific transcriptomic shift in glandular alveolar and hormone-sensing luminal epithelium subtypes. These cells begin expressing a cocktail of secretory factors, which the authors named "mammokines."
Among these factors, Lipocalin-2 (LCN2) emerged as a primary regulator. Other identified mammokines include LRG1, Enho (Adropin), and Angptl4. These proteins communicate directly with nearby adipocytes to inhibit UCP1 expression and promote the maintenance of white adipocyte identity.
The Sympathetic-Ductal Axis
One of the study's most striking findings is the physical connection between the nervous system and the mammary ducts. Using whole-tissue immunofluorescence and 3D visualization, the researchers revealed previously undescribed contact points between sympathetic nerves and the ductal epithelium.
When the sympathetic nervous system is activated by cold, it doesn't just signal to adipocytes; it also signals to the mammary ducts. This activation prompts the ducts to release mammokines, which then act on the surrounding fat cells. This dual signaling creates a regulatory loop where the mammary gland can override the general systemic drive for thermogenesis. Functional validation showed that both in vivo and ex vivo ablation of this ductal epithelium enhances the thermogenic gene program in scWAT.
LCN2: The Primary Thermogenic Brake
The role of LCN2 was validated through extensive functional experiments. In mice where LCN2 was knocked out, the mgWAT showed a significant increase in UCP1 expression and beiging during cold exposure, losing its characteristic resistance. Conversely, when LCN2 was reintroduced specifically into the mammary gland using adeno-associated virus (AAV) vectors, the thermogenic suppression was restored.
Interestingly, LCN2 does more than just block energy burning; it also appears to promote "fat-making" (adipogenesis) by increasing the expression of markers like Zfp423 and Lep (Leptin). This suggests that mammokines shift the metabolic balance of the tissue from energy expenditure to energy storage.
Evolutionary Logic: Protecting the Milk Supply
Why would female biology evolve a mechanism to resist heat production? The authors propose an evolutionary trade-off. Fat is the primary fuel source for lactation, an energetically demanding process essential for reproductive success. By "hijacking" the cold response to preserve mammary fat, the body ensures that energy remains available for future offspring, even if it means less efficient temperature regulation for the mother.
This is supported by trajectory inference analysis using Slingshot, which showed that cold-exposed luminal cells enter a transcriptomic state resembling "post-involution" (PI)—the phase after lactation ends when the mammary gland must rapidly rebuild its lipid stores. This suggests the cold response utilizes an existing fat-preservation program.
Conclusion and Future Directions
This research redefines the mammary gland as a highly active metabolic organ that exerts local and potentially systemic control over energy balance. While the study was conducted in mice, the discovery of the mammokine secretome opens new avenues for understanding human metabolic health, particularly regarding sex-based differences in obesity and the regulation of adipose tissue.
Future research will likely focus on the synergistic effects of the broader mammokine profile and whether these pathways can be targeted to treat metabolic disorders without disrupting essential reproductive functions.
Summary updated